Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
SHIP HEALTHCARE, 2% Increase in Ordinary Profit, Update Record High for Third Consecutive Term, Dividend Raised by 2 yen
3360 SHIP HEALTHCARE HOLDINGS, INC. 【J-GAAP】
Earnings ReportSHIP HEALTHCARE HOLDINGS, INC. <3360> [TSE Prime] announced its financial results after the market closed on May 13th (15:30). The consolidated ordinary profit for the fiscal year ending March 2025 increased 3.2% from the previous period to 26 billion yen. For the fiscal year ending March 2026, the consolidated ordinary profit is expected to grow by 1.8% to 26.5 billion yen, marking the third consecutive term of record-high profits. This will be the 23rd consecutive term of revenue and the third consecutive term of profit growth.
At the same time, the company has decided to increase the dividend this fiscal year to 60 yen, an increase of 2 yen from the previous fiscal year.
In the most recent three-month period, from January to March (4Q), the consolidated ordinary profit amounted to 9.47 billion yen, an increase of 0.5% compared to the same period last year. However, the operating profit margin remained almost flat, changing from 5.3% in the same period last year to 5.2%.
Kabutan News
Actual Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Mar, 2023 | 572,285 | 21,144 | 20,607 | 12,063 | 127.9 | 42 | May 12, 2023 | J-GAAP |
| Mar, 2024 | 630,988 | 24,539 | 25,219 | 13,799 | 146.3 | 50 | May 10, 2024 | J-GAAP |
| Mar, 2025 | 678,229 | 24,779 | 26,023 | 15,128 | 160.3 | 58 | May 13, 2025 | J-GAAP |
| YoY | +7.5% | +1.0% | +3.2% | +9.6% | +9.6% |
Full Year Results vs. Previous Guidance
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Mar, 2025 Guidance | 640,000 | 26,000 | 26,000 | 15,000 | 159.0 | 58 | Mar 7, 2025 | J-GAAP |
| Mar, 2025 Results | 678,229 | 24,779 | 26,023 | 15,128 | 160.3 | 58 | May 13, 2025 | J-GAAP |
| Revision Rate | +6.0% | -4.7% | +0.1% | +0.9% | +0.9% |
Current Period Guidance
H1 Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Apr - Sep, 2024 | 310,032 | 7,743 | 8,414 | 5,539 | 58.7 | 0 | Nov 8, 2024 | J-GAAP |
| Apr - Sep, 2025 Guidance | 315,000 | 8,000 | 8,500 | 5,500 | 59.3 | 0 | May 13, 2025 | J-GAAP |
| YoY | +1.6% | +3.3% | +1.0% | -0.7% | +1.0% |
Current Period Guidance
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Mar, 2024 | 630,988 | 24,539 | 25,219 | 13,799 | 146.3 | 50 | May 10, 2024 | J-GAAP |
| Mar, 2025 | 678,229 | 24,779 | 26,023 | 15,128 | 160.3 | 58 | May 13, 2025 | J-GAAP |
| Mar, 2026 Guidance | 700,000 | 26,000 | 26,500 | 15,500 | 168.4 | 60 | May 13, 2025 | J-GAAP |
| YoY | +3.2% | +4.9% | +1.8% | +2.5% | +5.1% |
Quarterly Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Operating Profit Margin | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Jan - Mar, 2024 | 177,931 | 9,409 | 9,431 | 6,575 | 69.7 | 5.3 | May 10, 2024 | J-GAAP |
| Apr - Jun, 2024 | 155,219 | 3,507 | 4,491 | 3,081 | 32.7 | 2.3 | Aug 9, 2024 | J-GAAP |
| Jul - Sep, 2024 | 154,813 | 4,236 | 3,923 | 2,458 | 26.1 | 2.7 | Nov 8, 2024 | J-GAAP |
| Oct - Dec, 2024 | 182,240 | 7,378 | 8,131 | 4,978 | 52.8 | 4.0 | Feb 7, 2025 | J-GAAP |
| Jan - Mar, 2025 | 185,957 | 9,658 | 9,478 | 4,611 | 48.9 | 5.2 | May 13, 2025 | J-GAAP |
| YoY | +4.5% | +2.6% | +0.5% | -29.9% | -29.9% |
Related Articles
PeptiDream, Jan-Mar (1Q) Net Income Loss Widens
OPTORUN, Jan-Mar (1Q) Ordinary Profit Decreases by 83%
Nitori, 5% Increase in Ordinary Profit for The Current Fiscal Year, Dividend Raised by 2 yen
SANTEN PHARMA, 6% Decrease in Net Income for The Current Fiscal Year, Dividend Raised by 2 yen
StemCell Institute, 5% Increase in Ordinary Profit, Update Record High for Third Consecutive Term
robot home, Jan-Mar (1Q) Ordinary Profit Decreases by 71%
Interspace, First Half Ordinary Profit Decreases by 34%, Jan-Mar Ordinary Profit Decreases by 59%
Shikino High-Tech, 2.4 times Increase in Ordinary Profit for The Current Fiscal Year
Will Smart, Jan-Mar (1Q) Ordinary Profit loss of 54 Million Yen
MIRAIT ONE, 24% Increase in Ordinary Profit for The Current Fiscal Year, Dividend Raised by 10 yen